WallStreetZenWallStreetZen

NASDAQ: HEPA
Hepion Pharmaceuticals Inc Stock Ownership - Who owns Hepion Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Hepion Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Peter WijngaardDirector2023-11-272,500$3.05
$7.63kBuy
Peter WijngaardDirector2023-11-242,500$3.09
$7.73kBuy
Peter WijngaardDirector2023-09-191,000$5.64
$5.64kBuy
Robert T. FosterCEO and Director2023-09-181,600$5.60
$8.96kBuy
Peter WijngaardDirector2023-09-151,000$5.82
$5.82kBuy
Peter WijngaardDirector2023-09-15861$5.37
$4.62kBuy
Peter WijngaardDirector2023-09-15139$5.45
$757.55Buy
Robert T. FosterCEOCSO and Director2023-09-151,600$5.40
$8.64kBuy

1 of 1

HEPA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HEPA insiders and whales buy or sell their stock.

HEPA Shareholders

What type of owners hold Hepion Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Gabriel Cerrone94.72%5,183,579$7.31MInsider
Donald E. Garlikov60.67%3,320,000$4.68MInsider
James Sapirstein9.01%492,819$694.87kInsider
Armistice Capital LLC7.64%418,000$589.38kInstitution
Vanguard Group Inc2.93%160,345$226.09kInstitution
Blackrock Inc1.52%82,954$116.97kInstitution
John Z. Sullivanbolyai1.07%58,681$82.74kInsider
Robert T. Foster0.92%50,470$71.16kInsider
Geode Capital Management LLC0.64%34,909$49.22kInstitution
State Street Corp0.29%15,676$22.10kInstitution

1 of 3

HEPA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HEPA7.54%92.46%Net Buying
ASLN0.79%0.00%
CYCN9.83%90.17%Net Buying
CANF0.02%0.00%
VIRI4.47%5.34%Net Buying
View Top Biotech Stocks

Hepion Pharmaceuticals Stock Ownership FAQ

Who owns Hepion Pharmaceuticals?

Hepion Pharmaceuticals (NASDAQ: HEPA) is owned by 13.64% institutional shareholders, 167.20% Hepion Pharmaceuticals insiders, and 0.00% retail investors. Gabriel Cerrone is the largest individual Hepion Pharmaceuticals shareholder, owning 5.18M shares representing 94.72% of the company. Gabriel Cerrone's Hepion Pharmaceuticals shares are currently valued at $7.72M.

If you're new to stock investing, here's how to buy Hepion Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.